CorMedix Inc.
CRMD
$6.38
$0.010.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 311.71M | 214.30M | 121.48M | 82.55M | 43.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 311.71M | 214.30M | 121.48M | 82.55M | 43.47M |
| Cost of Revenue | 22.19M | 12.15M | 5.22M | 3.86M | 3.09M |
| Gross Profit | 289.52M | 202.16M | 116.27M | 78.69M | 40.39M |
| SG&A Expenses | 96.07M | 82.06M | 58.76M | 57.81M | 58.70M |
| Depreciation & Amortization | 13.77M | 3.68M | 104.00K | 104.00K | 104.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 151.37M | 110.35M | 72.17M | 68.08M | 65.83M |
| Operating Income | 160.34M | 103.95M | 49.32M | 14.47M | -22.36M |
| Income Before Tax | 150.02M | 107.03M | 51.68M | 17.18M | -19.33M |
| Income Tax Expenses | -13.04M | -55.47M | 521.30K | -200.00 | -1.40M |
| Earnings from Continuing Operations | 163.06 | 162.50 | 51.16 | 17.18 | -17.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 163.06M | 162.50M | 51.16M | 17.18M | -17.93M |
| EBIT | 160.34M | 103.95M | 49.32M | 14.47M | -22.36M |
| EBITDA | 174.89M | 108.20M | 49.85M | 14.92M | -22.05M |
| EPS Basic | 2.20 | 2.26 | 0.78 | 0.24 | -0.33 |
| Normalized Basic EPS | 1.35 | 0.95 | 0.49 | 0.15 | -0.22 |
| EPS Diluted | 2.00 | 2.06 | 0.75 | 0.22 | -0.33 |
| Normalized Diluted EPS | 1.20 | 0.88 | 0.47 | 0.14 | -0.22 |
| Average Basic Shares Outstanding | 287.94M | 270.61M | 253.51M | 243.20M | 235.46M |
| Average Diluted Shares Outstanding | 321.03M | 288.62M | 261.23M | 246.93M | 235.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |